(Q37120290)

18 August 2017

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica (English)

1 reference

18 August 2017

1 reference

1 reference

0 references

2

Allan Hildesheim

0 references

Sholom Wacholder

4

Sholom Wacholder

0 references

Ana Cecilia Rodríguez

3

Ana C Rodríguez

0 references

Mark Schiffman

22

Mark Schiffman

1 reference

18 August 2017

1

Rolando Herrero

1 reference

18 August 2017

21

Douglas Lowy

1 reference

18 August 2017

19

John Schussler

1 reference

18 August 2017

Carolina Vargas-Porras

8

Carolina Porras

1 reference

18 August 2017

10

Diego Guillen

1 reference

18 August 2017

5

Concepción Bratti

1 reference

18 August 2017

6

Diane Solomon

1 reference

18 August 2017

Paula González

7

1 reference

18 August 2017

Silvia Jiménez

9

1 reference

18 August 2017

Jorge Morales

11

1 reference

18 August 2017

Mario Alfaro

12

1 reference

18 August 2017

Jean Cyr

13

1 reference

18 August 2017

Kerrygrace Morrisey

14

1 reference

18 August 2017

Yenory Estrada

15

1 reference

18 August 2017

Bernal Cortés

16

1 reference

18 August 2017

Lidia Ana Morera

17

1 reference

18 August 2017

Enrique Freer

18

1 reference

18 August 2017

John Schiller

20

1 reference

18 August 2017

Costa Rica Vaccine Trial (CVT) Group

23

1 reference

18 August 2017

language of work or name

English

0 references

publication date

18 July 2008

1 reference

18 August 2017

1 reference

18 August 2017

26

1 reference

18 August 2017

37

1 reference

18 August 2017

4795-4808

1 reference

Epidemiology of genital Chlamydia trachomatis infection among young women in Costa Rica

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Introducing human papillomavirus vaccines - questions remain

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Chapter 8: Screening for cervical cancer in developing countries.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Chapter 2: The burden of HPV-related cancers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

A controlled trial of a human papillomavirus type 16 vaccine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652516

Carcinogenicity of human papillomaviruses

3 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Human papillomavirus and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.002

An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18640170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18640170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.07.002

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18640170

1 reference